Add BrightSurf on Google Email

Ludwig-Maximilians-Universität München


Advance in breast cancer treatment

Researchers have successfully tested a new drug, trastuzumab deruxtecan, which significantly extends the lives of breast cancer patients with advanced HER2-positive disease and brain metastases. The treatment has been shown to increase survival times substantially, with over 90% of patients alive one year after treatment.

SourceLudwig-Maximilians-Universität München·JournalNature Medicine·DateOct 4, 2024

Brain development: extracellular vesicles facilitate cellular communication

Research led by Silvia Cappello reveals that extracellular vesicles play a crucial role in the development of the brain, facilitating communication between different cell types. The study found that these vesicles can transport specific molecular signals to the nucleus of recipient cells, inducing rapid transcriptional changes and infl...

SourceLudwig-Maximilians-Universität München·JournalCell Reports·TypeExperimental study·DateSep 25, 2024

Quantum physics: Describing chaotic systems

A research team led by Professor Monika Aidelsburger and Professor Immanuel Bloch found indications that chaotic many-body systems in the quantum realm can be described using fluctuating hydrodynamics. This approach simplifies the macroscopic description of such systems, obviating the need to engage with microscopic interactions.

SourceLudwig-Maximilians-Universität München·JournalNature Physics·TypeExperimental study·DateSep 9, 2024

Cytophysics: how cell nuclei squeeze through

LMU researchers investigated how cell nuclei change shape to migrate through tight spaces, revealing reversible nuclear deformation and adaptation of pulling and pushing forces. The study suggests a biphasic dependence of migration speed on channel width, with maximal transition rates at widths comparable to the nuclear diameter.

SourceLudwig-Maximilians-Universität München·JournalScience Advances·TypeImaging analysis·DateSep 2, 2024